Daniel Eng

As the demand for new medicines grows, so does the need for better information to manage and execute the R&D processes. There is huge pressure to make informed decisions, especially during the project's early stages when the risk is high and before downstream costs are added. Pf... (more)
© 2008 SYS-CON Media